Navigation Links
Clinical Update - Debio 9902 SR in Alzheimer's Disease
Date:3/4/2008

Successful DSMB Review From Ongoing Phase II BRAINz Study

LAUSANNE, Switzerland, March 4 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, announced today that following a meeting of the independent Data Safety Monitoring Board (DSMB), the Company received a recommendation to continue its Phase II BRAINz study with Debio 9902 SR (sustained release) for the treatment of Alzheimer's disease (AD),without modification.

The DSMB's objective is to monitor the well being and safety of patients participating in a study and to review the safety data throughout its duration.

"This recommendation by the DSMB authorising Debiopharm to continue the BRAINz study confirms the safety profile of Debio 9902 SR" said David Wilkinson, from MARC, Moorgreen Hospital, Southampton, England and Principal Investigator in the United Kingdom, who presented this recommendation at the 10th International Hong Kong Springfield Symposium on Advances in Alzheimer Therapy.

About Debio 9902 SR

Debio 9902 SR is a novel AChE inhibitor which is administered once every 4 weeks. It is transformed non-enzymatically into its active compound, huperzine A (hup A). Hup A has been used in China for centuries to treat distinct disorders such as memory loss, schizophrenia and hypertension, and is widely used in North America and Europe as a food additive to enhance cognition and neuroprotection. The dual mode of action of Debio 9902 SR as a N-methyl-D-aspartate receptor antagonist and an AChE inhibitor, positions it as a third generation anti-Alzheimer's product by improving the general condition and cognitive functions of affected patients as well as having the potential of being a neuroprotectant. In addition, Debio 9902 SR once a month formulation aims to increase the benefit of the treatment by offering a better safety profile compared to al
'/>"/>

SOURCE Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Winnick Family Clinical Research Center Celebrates 6th Anniversary
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
4. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
5. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
6. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
7. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
8. Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
9. Boston Scientific Announces Addition to Clinical Sciences Organization
10. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
11. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., CAMBRIDGE, Mass., Dec. 1 To ad...try and to promote its potential, a group of indiv...e Synthetic Biology Industry Association (SynBIA) ... the association is to provide a forum for individ...ndustry, address its opportunities and its challen...
(Date:12/1/2009)... SHANGHAI, Dec. 1 /PRNewswire-Asia/ -- Shanghai C...rma, a leading China-based Contract Research,Organ...he 2009 Deloitte,Technology Fast 50 China, ranking...companies in China. The award is a testament to Ch...from 2006 to 2008. , The results of the 2...
(Date:12/1/2009)...SPRINGFIELD, Ill., Dec. 1 Prairie ...nounce that it was recently awarded two statuettes... Nov. 13 in New York City. The CLIO Healthcare Awa...in the healthcare advertising industry and is an e...st recognized awards competitions for advertising,...
(Date:12/1/2009)... Enterprise level storage is now availab... without breaking the bank. , ... www.pacsdrive.com ), a medical imaging software...patible cloud storage service. The PacsDrive servi...iders to securely archive medical imaging in compl...
Breaking Biology Technology:Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2
...nnounced Tuesday its release of GroupWise Migrator... that automates the migration of server and deskto.... , ,Earlier versions of GroupWise Migrator for E...ress books, frequent contacts and personal distrib...rsion adds the ability to migrate large GroupWise ...
...oped by a research group headed by Nimmi Ramanujam... the University of Wisconsin-Madison, will be a "t...the chance for an accurate clinical diagnosis of b...trasound - two-dimensional pictures - to guide the... ensure that they are doing the biopsy at the righ...
...ilding better advertising campaigns may be to buil...dy from the University of Wisconsin-Oshkosh, consu...t the information they get from traditional advert...o online to learn more are likely to perform bette...estination. , ,Integrating ads with a web site can...
Other Biology Technology:Wingra Technologies releases new e-mail-message migration software 2Technology could enhance accuracy of breast biopsy 2To boost advertising results, consider improving your web site 2
(Date:11/30/2009)...e state of Antarctica,s climate and its relationsh...week (Tuesday 1 December) by the Scientific Commit...tarctic Climate Change and the Environment presen...ntifies areas for future scientific research, and ...have about Antarctic melting, sea-level rise and b...
(Date:11/30/2009)... team overcame a major hurdle plaguing the develop...d to more efficient catalysts used to produce hydr...chers reported Nov. 29 in Nature Materials the f...n metallic nanoparticles, the vaunted next-generat...me heat. , Gtz Veser, an associate professor and...
(Date:11/30/2009)...imental Biology are pleased to announce that Dr X...Scientifique (CNRS) in the Universit de Nice-Sophi...standing Paper Prize. ,The prize is awarded in rec...nded to encourage young scientists, says Hans Hop...we truly appreciate when authors submit their very...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Immucor to Announce Fiscal First Quarter Financial Results on Thursday October 1 2009 57569 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 2Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 3Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 5Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 6Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 7Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7
...earch into a new treatment for nerve damage caused...betic patients, say experts. , The treatment migh...d feet if early effects on nerve protection and re...in diabetes is the major cause of non-traumatic lo..., Scientists at The University of Manchester, work...
... did University of Alberta researchers discover th...? A little birdie told them. , In studying the sp...niversity of Alberta researchers were surprised to...hat showed how animals navigate. This study is the...only animals that had been raised in human-made en...
...pared with a long-used linear model, a correlation...o map complex gene interactions and pinpoint genes...ccording to new Brown University research. , The ...sing new tool for tracing human gene connections, ...cer and other diseases. Results appeared this week...
Other Biology News:Diabetic nerve therapy shows 'striking' results 2Chickadees can help humans get their bearings 2Researchers develop promising new gene network analysis method 2
Softwall Clean Room from Terra Universal, Inc.
...The first high-density serum biomarker chip to pro...ns. An antibody chip containing 120 human cancer s...l that enables biomarker discovery scientists to s...on, benefits of therapy and the likelihood of recu...
...Phosphate Sensor is a highly sensitive reagent for...t is a purified form of recombinant E. coli phosph...DCC, which is sensitive to changes in its environm...Phosphate Sensor is rapid and tight (Kd ~ 0.1 M), ...
Benchtop Ductless Exhaust Hood (Environmental Control Module) from Terra Universal, Inc.
Biology Products: